Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
DOP041: Etrolizumab population pharmacokinetics (Pop PK) and covariate analysis in patients with moderately to severely active ulcerative colitis (UC)
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 5 – Drug levels & biomarkers (Keywords: pharmacokinetics, etrolizumab, ulcerative colitis, population PK, covariates analysis)
Authors: Tracey Wei Xiaohui
DOP041: Impact of an education program on IBD patient's skills: one year results of the ECIPE randomized, controlled multicenter study.
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 5 - Improving the care and outcome of IBD patients (Keywords: clinical trials, therapeutics education)
Authors: Matthieu Allez
DOP042: Most anti-TNF injectors are stored under suboptimal conditions at home
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 5 - Improving the care and outcome of IBD patients (stoarage conditions, subcutaneous, spillage, immune-mediated inflammatory diseases)
Authors: M.J. de Jong
DOP043: Non-adherence to anti-TNF therapy predicts clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 5 - Improving the care and outcome of IBD patients (Keywords: adalimumab, IBD, infliximab, trough levels, adherence)
Authors: Mike van der Have
DOP044: Presence of anti-MZGP2 IgG and IgA antibodies assessed by 2 different ELISA assays is associated with younger age at onset, stricturing disease behavior, need for surgery and ASCA/anti-OMP PlusTM positivity in Crohns Disease
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 5 – Drug levels & biomarkers (Keywords: clinical trials, complications, IBD, CD, UC, microbiotica, Montreal classification)
Authors: Maria Papp
DOP044: Self-administered telemedicine reduces number of outpatient visits and days of absence from school in paediatric and adolescent patients with inflammatory bowel disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 5 - Improving the care and outcome of IBD patients (Keywords: adolescents, calproctectin, disease activity, IBD, CD, UC, monitoring, telemedicine, paediatrics)
Authors: Katrine Carlsen
DOP045: Self-administered telemedicine empowers paediatric and adolescent patients with Inflammatory Bowel Disease
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 5 - Improving the care and outcome of IBD patients (Keywords: adolescents, calproctectin, disease activity, IBD, CD, UC, monitoring, telemedicine, paediatrics)
Authors: Katrine Carlsen
DOP046: Mid- to Long-term Stability and Associated Prognostic Factors of Adalimumab Treatment for 1189 Patients with Crohn’s Disease: A Multicenter Cohort Study
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 6 - Short & long term efficacy of biologics (Keywords: adalimumab, anti-TNF, biologic treatment, IBD, CD)
Authors: Hiroki Tanaka
DOP046: Surgery and hospitalization rates during the first year after diagnosis in patients with inflammatory bowel diseases from the 2011 ECCO-EpiCom inception cohort
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes (Keywords: disease outcome, IBD)
Authors: Zuzana Vegh
DOP047: Long Term Outcome of Segmental Resection for Crohns Colitis: an Observational Study on 200 Patients
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes (Keywords: colectomy, CD,disease outcome)
Authors: Stefano Scaringi
DOP047: PYRAMID registry: an observational study of adalimumab in Crohn’s disease: results at year 7
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 6 - Short & long term efficacy of biologics
Authors: Walter Reinisch
DOP048: Predictors of post-operative endoscopic recurrence in Crohns disease: a prospective study of the REMIND group
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes (Keywords: disease outcome, endoscopic assesment, CD, ileocecal resection, postoperative)
Authors: Matthieu Allez
DOP049: Efficacy and safety of golimumab induction for moderate to severe ulcerative colitis in the United Kingdom: Results from the GO-COLITIS study
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 6 - Short & long term efficacy of biologics (Keywords: anti-TNF)
Authors: Chris Probert
DOP049: Involvement of cell fate pathways in early post-surgical recurrence of Crohns Disease
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes
Authors: Yamile Zabana
DOP050: Early thiopurine use is associated with a reduced risk of surgery in children and young people with Crohns disease but not in ulcerative colitis
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes (Keywords: mercaptopurine, adolescents, AZA, colectomy, IBD, CD, UC, immunosuppressive agents, surgery)
DOP051: Receiving corticosteroid therapy is associated with a poor outcome in patients with elderly-onset ulcerative colitis: a population-based study
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes
Authors: Benjamin Pariente
DOP052: Lower long-term colectomy rates with IFX than with CsA treatment in moderate to severe UC
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes (Keywords: biologig treatment, colectomy, UC, infliximab, cyclosporin)
Authors: Nicolette Duijvis
DOP052: Ozanimod induces histological response and remission: results from the TOUCHSTONE study, a randomized, double-blind, placebo-controlled trial of ozanimod, an oral S1P receptor modulator, in moderate to severe ulcerative colitis
Source: Presentation - ECCO 2016 Amsterdam Congress - Digital Oral Presentation Session 6 - Short & long term efficacy of biologics (Keywords: clinical trials, IBD, UC, trials)
Authors: William Sandborn
DOP053: Risk factors of pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Multivariate analysis
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 6 – Surgical outcomes (Keywords: endoscopic asessment, ileo-anal pouch anastomosis, pouch)
Authors: Hiroaki Ishii
DOP055: Combination therapy with infliximab and azathioprine improves Crohns disease outcome and infliximab tolerance compared to infliximab therapy alone
Source: Presentation - ECCO 2015 Barcelona Congress - Digital Oral Presentation Session 7 – Disease & therapy outcome (Keywords: anti-TNF, colectomy, complications, disease outcome, IBD, immunosuppressive agents, infliximab)
Authors: Guillaume Pineton de Chambrun